Konstantin A. Lesko

Dr. Konstantin A. Lesko

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
IKIgor E. Khatkov
Igor E. Khatkov
Dmitry S BordinDmitry S Bordin
Dmitry S Bordin
KLKonstantin A. Lesko
Konstantin A. Lesko
EDElena A. Dubtsova
Elena A. Dubtsova
NKNikolay Karnaukhov
Nikolay Karnaukhov
LVLudmila V. Vinokurova
Ludmila V. Vinokurova
Pancreatic fibrosis (PF) is a part of the pathogenesis in most pancreatic disorders and plays a crucial role in chronic pancreatitis development. The aim of our study was to investigate a relationship between PF grade and signs in resected pancreatic specimens, and the results of both multidetector computed tomography (MDCT) post-processing parameters and fibronectin (FN), hyaluronic acid (HA), matrix metalloproteinase (MMP)-1, and MMP-9 serum levels. The examination results of 74 patients were analyzed. The unenhanced pancreas density (UPD) value and contrast enhancement ratio (CER) showed statistically significant differences in groups with peri- and intralobular fibrosis grades, an integrative index of fibrosis, inflammation in pancreatic tissue, and pancreatic duct epithelium metaplasia, while the normalized contrast enhancement ratio in the venous phase (NCER VP) significantly differed with the perilobular fibrosis grade, integrative fibrosis index, and inflammation (p < 0.05). The blood FN level showed a weak positive correlation with the intralobular fibrosis grade (rho = 0.32, p = 0.008). The blood level of HA positively correlated with the presence of prominent and enlarged peripheral nerves (rho = 0.28, p = 0.02) and negatively correlated with the unenhanced pancreas density value (rho = −0.42, p = 0.0001). MMP-1 and MMP-9 values’ intergroup analysis and correlation did not show any statistical significance. The UPD value, NCER VP, and CER, as well as blood levels of FN and HA, could be used in non-invasive PF diagnosis.

21 January 2023 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
IKIgor E. Khatkov
Igor E. Khatkov
ETElena Y. Tyulyaeva
Elena Y. Tyulyaeva
KLKonstantin A. Lesko
Konstantin A. Lesko
EDElena A. Dubtsova
Elena A. Dubtsova
Dmitry S BordinDmitry S Bordin
Dmitry S Bordin
КАКирюкова Мария Анатольевна
Кирюкова Мария Анатольевна
Chronic pancreatitis is one of the most challenging disorders from the perspective of its early diagnosis and effective treatment. Within the last decade, the diagnosis of early chronic pancreatitis has been firmly introduced into the practice of gastroenterology. The delineation of this form as an initial stage of chronic pancreatitis is based on the need in early and effective treatment that could cease the progression of the disease and reduce the possibility of its complications. The diagnostic criteria of chronic pancreatitis have been described in details in the literature; however, specifics of the diagnosis in its early stage have been scarcely highlighted. Chronic pancreatitis is commonly diagnosed with a number of imaging techniques (they can show abnormalities in morphology of the pancreas), as well as laboratory tests (showing functional organ deficit). However, morphological and imaging techniques are insufficient for the diagnosis of the early chronic pancreatitis. A new integral strategy towards early diagnosis seems necessary, that would consider not only the morphology, but also potential etiology, risk factors of the disease and its complications in patients with suspected chronic pancreatitis. The review of the literature presents the definition of the early pancreatitis and discusses the potential of imaging techniques and functional tests in its diagnosis. An adequate strategy for the diagnosis of the early pancreatitis is formulated, based on an individual patient characteristic with suspected early chronic pancreatitis, namely, risk factors, clinical manifestations, imaging results and serological biomarkers.

1 April 2023 in Automatic Documentation and Mathematical Linguistics
Verified
Journal Article
Closed access
PDF file
OSO. P. Shesternikova
O. P. Shesternikova
VFV. K. Finn
V. K. Finn
KLKonstantin A. Lesko
Konstantin A. Lesko
LVL. V. Vinokurova
L. V. Vinokurova
The article describes the application of algorithmic tools for finding empirical regularities using the JSM method of automated research support to an arra

1 April 2024 in Russian Journal of Evidence-Based Gastroenterology
Verified
Journal Article
Closed access
ESE.I. Shurygina
E.I. Shurygina
NMN.V. Makarenko
N.V. Makarenko
NKNikolay Karnaukhov
Nikolay Karnaukhov
YNYu.B. Nikonova
Yu.B. Nikonova
EDE.A. Dubtsova
E.A. Dubtsova
IKI.E. Khatkov
I.E. Khatkov
Objective. This review provides an in-depth analysis of the current landscape in assessing pancreatic fibrosis. Key points. Pancreatic fibrosis is a common feature in various diseases, including inflammatory and neoplastic conditions, exacerbating their progression. Timely identification of fibrotic changes in pancreatic tissue plays a crucial role in halting or slowing down the advancement of glandular damage. Evaluation methods for fibrosis encompass both invasive and non-invasive approaches. Histological assessment remains the most dependable method for gauging the extent of pancreatic fibrosis. Among the numerous scales for the morphological assessment of pancreatic fibrosis, the system proposed by G. Kloppel, B. Maillet, which evaluates peri- and intralobular fibrosis along with an integrative index, currently stands out as the most applicable for research purposes. In the pursuit of novel non-invasive diagnostic methods for pancreatic tissue fibrosis, researchers are actively developing laboratory biomarkers such as matrix metalloproteinases and specific blood cytokines, as well as instrumental techniques like ultrasound, computed tomography, and magnetic resonance imaging. Conclusion. Each method possesses unique capabilities and limitations associated with the patient’s condition, the prevalence of the fibrotic process, and the presence of comorbidities. The most effective approach involves the integrated use of data obtained from an objective assessment of pancreatic tissue fibrosis. Notably, there is a current lack of standardized scales for the reproducibility of laboratory, instrumental and histological systems in assessing pancreatic fibrosis.

1 January 2020 in Doctor.Ru
Verified
Journal Article
Open access
ADA.S. Loginov Moscow Clinical Scientific and Practical Centre of the Moscow Healthcare Department
A.S. Loginov Moscow Clinical Scientific and Practical Centre of the Moscow Healthcare Department
KLKonstantin A. Lesko
Konstantin A. Lesko
RMRussian Federation Moscow
Russian Federation Moscow
GVG.G. Varvanina
G.G. Varvanina
Dmitry S BordinDmitry S Bordin
Dmitry S Bordin
LVL.V. Vinokurova
L.V. Vinokurova
Study Objective: to search for novel approaches to non-invasive diagnosis of pancreatic fibrosis in chronic pancreatitis (CP) patients. Study Design: prospective comparative non-randomised study. Materials and Methods. 43 subjects were examined: 22 (51.2%) patients with calcific CP and 21 (48.8%) patients with CP resulting from acute pancreatitis with pancreonecrosis, aged 35 to 82 years old. All patients underwent multislice computer-aided tomography (CT) of abdomen with IV contrast, and had their fibronectin (FN), С-peptide and faecal pancreatic elastase 1 concentrations measured. Study Results. There were no differences in C-peptide between study groups (p = 0,18). Faecal elastase 1 concentration (108.36 ± 144 μg/g) was significantly lower in calcific CP (p = 0.03) vs. patients with post-pancreonecrosis CP (185.67 ± 145.1 μg/g). Blood FN level negatively correlated with CP severity (M-ANNHEIM system) (r = –0.36, p = 0.018). In calcific CP, median contrast ratio (1.01 ± 0.06) was significantly higher (p = 0.033) than in post-pancreonecrosis CP (0.95 ± 0.14). Conclusion. Patients with calcific CP demonstrated more severe exocrine insufficiency. Decreased FN levels in severe CP are likely to be due to long-term increased FN intake because of pacreatic fibrosis. Pancreatic fibrosis augmentation impacts pancreas contrast study and results in higher contrast ratio at CT. Therefore, it allows using this parameter for non-invasive diagnosis of pancreas fibrosis in patients with CP. Keywords: fibrosis, chronic pancreatitis, pancreas, computer-aided tomography.

22 September 2025 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
IKI. E. Khatkov
I. E. Khatkov
VTV. V. Tsvirkun
V. V. Tsvirkun
PTP. S. Tyutyunnik
P. S. Tyutyunnik
AAA. R.O. Aliev
A. R.O. Aliev
SAS. M. Akhmadzoda
S. M. Akhmadzoda
ASA. V. Shabunin
A. V. Shabunin
In 2023, with the approval of the leadership of the Hepato-Pancreato-Biliary Association of Commonwealth of Independent States, a consensus study was initiated and conducted on the diagnosis, management, and follow-up of patients with serous and mucinous neoplasms of the pancreas. Based on an extensive literature review, responses to each of the 22 questions posed were formulated and compiled into a Consensus Document. A total of 44 experts representing 27 institutions across 9 countries participated in the preparation of the Consensus. The Delphi method was employed for voting, and ultimately, including the results of votes on selected statements during the final conference, consensus was achieved on all questions.